Briggs Morrison - Jun 26, 2024 Form 4 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
Director
Signature
/s/ Richard Morris, as Attorney-in-Fact for Briggs Morrison
Stock symbol
CARM
Transactions as of
Jun 26, 2024
Transactions value $
$0
Form type
4
Date filed
6/27/2024, 04:54 PM
Previous filing
Jun 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CARM Stock Option (Right to Buy) Award $0 +19.4K $0.00 19.4K Jun 26, 2024 Common Stock 19.4K $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest with respect to all of the shares underlying such option on the first anniversary of the grant date or, if earlier, immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to the non-employee director's continued service as a director.